Wearable sensor-based objective assessment of motor symptoms in Parkinson’s disease

Journal of Neural Transmission

Volumn 123, Issue 1, 2016, Pages 57-64

  Ossig, Christiana ^a   Antonini, Angelo ^b   Buhmann, Carsten ^c   Classen, Joseph ^d   Csoti, Ilona ^e   Falkenburger, Björn ^f   Schwarz, Michael ^g   Winkler, Jürgen ^h   Storch, Alexander ^i,j,k  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Dipartimento Cardiovascolare Ospedale   (Italy)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e Gertrudis Kliniken im Parkinson Zentrum   (Germany)

^f RWTH AACHEN UNIVERSITY   (Germany)

^g KLINIKUM DORTMUND   (Germany)

^h UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

ⁱ DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^j GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^k UNIVERSITY OF ROSTOCK   (Germany)

more..

Author keywords

Accelerometer; Clinical scores; Gyroscope; Motor symptoms; Objective measurement; Parkinson s disease (PD)

Indexed keywords

ABNORMAL INVOLUNTARY MOVEMENT SCALE; ACCELEROMETER; BRADYKINESIA; DEVICE SAFETY; DISEASE SEVERITY; DYSKINESIA; ELECTRICAL EQUIPMENT; GYROSCOPE; HUMAN; LOCOMOTION; MEDICAL DEVICE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PATTERN RECOGNITION; PRIORITY JOURNAL; REVIEW; SENSOR; SHUFFLING GAIT; TREMOR; UNIFIED PARKINSON DISEASE RATING SCALE; WEARABLE SENSOR; AMBULATORY MONITORING; DEVICES; MEDLINE; MOVEMENT (PHYSIOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA;

HUMANS; MONITORING, AMBULATORY; MOVEMENT; PARKINSON DISEASE; PUBMED; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 84955211346     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-015-1439-8     Document Type: Review

References (52)

1. Achey M, Aldred JL, Aljehani N, Bloem BR, Biglan KM, Chan P, Cubo E, Dorsey ER, Goetz CG, Guttman M, Hassan A, Khandhar SM, Mari Z, Spindler M, Tanner CM, van den Haak P, Walker R, Wilkinson JR (2014) The past, present, and future of telemedicine for Parkinson’s disease. Mov Disord 29(7):871–883. doi:10.1002/mds.25903
2. Bain PG, Findley LJ, Atchison P, Behari M, Vidailhet M, Gresty M, Rothwell JC, Thompson PD, Marsden CD (1993) Assessing tremor severity. J Neurol Neurosurg Psychiatry 56(8):868–873
3. Barth J, Klucken J, Kugler P, Kammerer T, Steidl R, Winkler J, Hornegger J, Eskofier B (2011) Biometric and mobile gait analysis for early diagnosis and therapy monitoring in Parkinson’s disease. Conf Proc IEEE Eng Med Biol Soc 2011:868–871. doi:10.1109/IEMBS.2011.6090226
4. Barth J, Sunkel M, Bergner K, Schickhuber G, Winkler J, Klucken J, Eskofier B (2012) Combined analysis of sensor data from hand and gait motor function improves automatic recognition of Parkinson’s disease. Conf Proc IEEE Eng Med Biol Soc 2012:5122–5125. doi:10.1109/EMBC.2012.6347146
5. Bergmann JH, Chandaria V, McGregor A (2012) Wearable and implantable sensors: the patient’s perspective. Sensors (Basel) 12(12):16695–16709. doi:10.3390/s121216695
6. Bhidayasiri R, Petchrutchatachart S, Pongthornseri R, Anan C, Dumnin S, Thanawattano C (2014) Low-cost, 3-dimension, office-based inertial sensors for automated tremor assessment: technical development and experimental verification. J Parkinsons Dis 4(2):273–282. doi:10.3233/JPD-130311
7. Checkoway H, Nelson LM (1999) Epidemiologic approaches to the study of Parkinson’s disease etiology. Epidemiology 10(3):327–336
8. Chien SL, Lin SZ, Liang CC, Soong YS, Lin SH, Hsin YL, Lee CW, Chen SY (2006) The efficacy of quantitative gait analysis by the GAITRite system in evaluation of parkinsonian bradykinesia. Parkinsonism Relat Disord 12(7):438–442. doi:10.1016/j.parkreldis.2006.04.004
9. de Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M, Fratiglioni L, Lobo A, Martinez-Lage J, Trenkwalder C, Hofman A (2000) Prevalence of Parkinson’s disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54(11 Suppl 5):S21–S23
10. Del Din S, Godfrey A, Rochester L (2015) Validation of an accelerometer to quantify a comprehensive battery of gait characteristics in healthy older adults and Parkinson’s disease: toward clinical and at home use. IEEE J Biomed Health Inform. doi:10.1109/JBHI.2015.2419317
11. Deuschl G, Krack P, Lauk M, Timmer J (1996) Clinical neurophysiology of tremor. J Clin Neurophysiol 13(2):110–121
12. Deuschl G, Bain P, Brin M (1998) Consensus statement of the movement disorder society on tremor. Ad Hoc Sci Comm Mov Disord 13(Suppl 3):2–23
13. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68(5):384–386. doi:10.1212/01.wnl.0000247740.47667.03
14. Fahn S, Elton RL, Committee UD (1987) The unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne DB (eds) Recent developments in Parkinson’s disease. Macmillan Healthcare Information, Florham Park, pp 293–304
15. Fahn S, Tolosa E, Concepcion M (1993) Clinical rating scale for tremor. In: Jankovic J, Tolosa E (eds) Parkinson’s disease and movement disorders, 2nd edn. Williams and Wilkins, Baltimore, pp 271–280
16. Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, Tanner C, Marek K (2004) Levodopa and the progression of Parkinson’s disease. N Engl J Med 351(24):2498–2508. doi:10.1056/NEJMoa033447
17. Goetz CG, Leurgans S, Hinson VK, Blasucci LM, Zimmerman J, Fan W, Nguyen T, Hsu A (2008a) Evaluating Parkinson’s disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments. Mov Disord 23(10):1479–1482. doi:10.1002/mds.22127
18. Goetz CG, Nutt JG, Stebbins GT (2008b) The unified dyskinesia rating scale: presentation and clinimetric profile. Mov Disord 23(16):2398–2403. doi:10.1002/mds.22341
19. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N (2008c) Movement disorder society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129–2170. doi:10.1002/mds.22340
20. Gouelle A (2014) Use of functional ambulation performance score as measurement of gait ability: review. J Rehabil Res Dev 51(5):665–674. doi:10.1682/JRRD.2013.09.0198
21. Griffiths RI, Kotschet K, Arfon S, Xu ZM, Johnson W, Drago J, Evans A, Kempster P, Raghav S, Horne MK (2012) Automated assessment of bradykinesia and dyskinesia in Parkinson’s disease. J Parkinsons Dis 2(1):47–55. doi:10.3233/JPD-2012-11071
22. Hauser RA, Friedlander J, Zesiewicz TA, Adler CH, Seeberger LC, O’Brien CF, Molho ES, Factor SA (2000) A home diary to assess functional status in patients with Parkinson’s disease with motor fluctuations and dyskinesia. Clin Neuropharmacol 23(2):75–81
23. Hauser RA, Russ H, Haeger DA, Bruguiere-Fontenille M, Muller T, Wenning GK (2006) Patient evaluation of a home diary to assess duration and severity of dyskinesia in Parkinson disease. Clin Neuropharmacol 29(6):322–330. doi:10.1097/01.WNF.0000229546.81245.7F
24. Horne MK, McGregor S, Bergquist F (2015) An objective fluctuation score for Parkinson’s disease. PLoS One 10(4):e0124522. doi:10.1371/journal.pone.0124522
25. Jang W, Han J, Park J, Kim JS, Cho JW, Koh SB, Chung SJ, Kim IY, Kim HT (2013) Waveform analysis of tremor may help to differentiate Parkinson’s disease from drug-induced parkinsonism. Physiol Meas 34(3):N15–N24. doi:10.1088/0967-3334/34/3/N15
26. Keijsers NL, Horstink MW, van Hilten JJ, Hoff JI, Gielen CC (2000) Detection and assessment of the severity of levodopa-induced dyskinesia in patients with Parkinson’s disease by neural networks. Mov Disord 15(6):1104–1111
27. Keijsers NL, Horstink MW, Gielen SC (2003) Automatic assessment of levodopa-induced dyskinesias in daily life by neural networks. Mov Disord 18(1):70–80. doi:10.1002/mds.10310
28. Klucken J, Barth J, Kugler P, Schlachetzki J, Henze T, Marxreiter F, Kohl Z, Steidl R, Hornegger J, Eskofier B, Winkler J (2013) Unbiased and mobile gait analysis detects motor impairment in Parkinson’s disease. PLoS One 8(2):e56956. doi:10.1371/journal.pone.0056956
29. Lieber B, Taylor B, Appelboom G, McKhann G, Connolly ES Jr (2015) Motion sensors to assess and monitor medical and surgical management of Parkinson’s disease. World Neurosurg. doi:10.1016/j.wneu.2015.03.024
30. Louter M, Maetzler W, Prinzen J, van Lummel RC, Hobert M, Arends JB, Bloem BR, Streffer J, Berg D, Overeem S, Liepelt-Scarfone I (2015) Accelerometer-based quantitative analysis of axial nocturnal movements differentiates patients with Parkinson’s disease, but not high-risk individuals, from controls. J Neurol Neurosurg Psychiatry 86(1):32–37. doi:10.1136/jnnp-2013-306851
31. Maetzler W, Domingos J, Srulijes K, Ferreira JJ, Bloem BR (2013) Quantitative wearable sensors for objective assessment of Parkinson’s disease. Mov Disord 28(12):1628–1637. doi:10.1002/mds.25628
32. May PR, Lee MA, Bacon RC (1983) Quantitative assessment of neuroleptic-induced extrapyramidal symptoms: clinical and nonclinical approaches. Clin Neuropharmacol 6(Suppl 1):S35–S51
33. McDonough AL, Batavia M, Chen FC, Kwon S, Ziai J (2001) The validity and reliability of the GAITRite system’s measurements: a preliminary evaluation. Arch Phys Med Rehabil 82(3):419–425. doi:10.1053/apmr.2001.19778
34. Morris S, Morris ME, Iansek R (2001) Reliability of measurements obtained with the Timed “Up & Go” test in people with Parkinson disease. Phys Ther 81(2):810–818
35. Muro-de-la-Herran A, Garcia-Zapirain B, Mendez-Zorrilla A (2014) Gait analysis methods: an overview of wearable and non-wearable systems, highlighting clinical applications. Sensors (Basel) 14(2):3362–3394. doi:10.3390/s140203362
36. Nelson AJ, Zwick D, Brody S, Doran C, Pulver L, Rooz G, Sadownick M, Nelson R, Rothman J (2002) The validity of the GaitRite and the functional ambulation performance scoring system in the analysis of Parkinson gait. NeuroRehabilitation 17(3):255–262
37. Palmerini L, Mellone S, Avanzolini G, Valzania F, Chiari L (2013) Quantification of motor impairment in Parkinson’s disease using an instrumented timed up and go test. IEEE Trans Neural Syst Rehabil Eng 21(4):664–673. doi:10.1109/TNSRE.2012.2236577
38. Papapetropoulos SS (2012) Patient diaries as a clinical endpoint in Parkinson’s disease clinical trials. CNS Neurosci Ther 18(5):380–387. doi:10.1111/j.1755-5949.2011.00253.x
39. Patel S, Hughes R, Huggins N, Standaert D, Growdon J, Dy J, Bonato P (2008) Using wearable sensors to predict the severity of symptoms and motor complications in late stage Parkinson’s Disease. Conf Proc IEEE Eng Med Biol Soc 2008:3686–3689. doi:10.1109/IEMBS.2008.4650009
40. Patel S, Lorincz K, Hughes R, Huggins N, Growdon J, Standaert D, Akay M, Dy J, Welsh M, Bonato P (2009) Monitoring motor fluctuations in patients with Parkinson’s disease using wearable sensors. IEEE Trans Inf Technol Biomed 13(6):864–873. doi:10.1109/TITB.2009.2033471
41. Podsiadlo D, Richardson S (1991) The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39(2):142–148
42. Pulliam CL, Burack MA, Heldman DA, Giuffrida JP, Mera TO (2014) Motion sensor dyskinesia assessment during activities of daily living. J Parkinsons Dis 4(4):609–615. doi:10.3233/JPD-140348
43. Pullman SL (1998) Spiral analysis: a new technique for measuring tremor with a digitizing tablet. Mov Disord 13(Suppl 3):85–89
44. Ramaker C, Marinus J, Stiggelbout AM, Van Hilten BJ (2002) Systematic evaluation of rating scales for impairment and disability in Parkinson’s disease. Mov Disord 17(5):867–876. doi:10.1002/mds.10248
45. Stacy MA, Elble RJ, Ondo WG, Wu SC, Hulihan J (2007) Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor. Mov Disord 22(6):833–838. doi:10.1002/mds.21412
46. Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR (2002) Patient non-compliance with paper diaries. BMJ 324(7347):1193–1194
47. Tao W, Liu T, Zheng R, Feng H (2012) Gait analysis using wearable sensors. Sensors (Basel) 12(2):2255–2283. doi:10.3390/s120202255
48. Tsipouras MG, Tzallas AT, Fotiadis DI, Konitsiotis S (2011) On automated assessment of Levodopa-induced dyskinesia in Parkinson’s disease. Conf Proc IEEE Eng Med Biol Soc 2011:2679–2682. doi:10.1109/IEMBS.2011.6090736
49. Tsipouras MG, Tzallas AT, Rigas G, Tsouli S, Fotiadis DI, Konitsiotis S (2012) An automated methodology for levodopa-induced dyskinesia: assessment based on gyroscope and accelerometer signals. Artif Intell Med 55(2):127–135. doi:10.1016/j.artmed.2012.03.003
50. van Uden CJ, Besser MP (2004) Test-retest reliability of temporal and spatial gait characteristics measured with an instrumented walkway system (GAITRite). BMC Musculoskelet Disord 5:13. doi:10.1186/1471-2474-5-13
51. Wile DJ, Ranawaya R, Kiss ZH (2014) Smart watch accelerometry for analysis and diagnosis of tremor. J Neurosci Methods 230:1–4. doi:10.1016/j.jneumeth.2014.04.021
52. Yanagisawa N, Fujimoto S, Tamaru F (1989) Bradykinesia in Parkinson’s disease: disorders of onset and execution of fast movement. Eur Neurol 29(Suppl 1):19–28